Warp Sciences Inc. — SEC Form D Filing

Warp Sciences Inc. filed an SEC Form D on October 23, 2026, reporting $194.61M raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
October 23, 2026
Amount reported
$194.61M
Round stage
Series A
Industry
Biotechnology
Website
https://warp.xyz/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Drug discovery relies on slow, repetitive experimental cycles that can take years and thousands of compounds to yield a promising candidate. Furthermore, foundational chemistry has largely shifted overseas and remains heavily dependent on manual labor.

Solution

Warp is a U.S.-based chemistry contract research organization (CRO) that combines expert chemists, AI, and robotics in automated laboratories to synthesize molecules and speed up drug discovery.

Why now

Advances in laboratory robotics and foundation AI models make high-throughput automated synthesis feasible, coinciding with geopolitical and supply chain incentives to bring critical drug discovery capabilities back to the United States.

Source: SEC EDGAR Form D filing